Insights

Digital treatment expansion Leayf emphasizes delivering addiction medicine and therapy through multiple modalities including mobile, desktop, and in-person formats. This suggests a sales opportunity around partnerships or integrations with telehealth platforms, mobile health app ecosystems, and corporate wellness programs to expand reach and streamline patient access.

Professional focus Targeting professionals with alcohol and drug issues indicates a market niche with potential interest from employers and high-value clients. Engage with corporate EAP programs, healthcare organizations, and professional associations to offer confidential, discreet treatment solutions that fit employer compliance and ROI metrics.

Tech-enabled care The claim of cutting-edge addiction medicine practices paired with tech-enabled therapy points to opportunities for technology partnerships, data-driven outcomes tracking, remote monitoring, and secure telemedicine capabilities that can differentiate Leayf in a competitive landscape.

Market positioning Positioning as the most innovative program in mental health care suggests a competitive edge for premium services. Sales efforts can emphasize innovation, result-driven case studies, and scalability to large clientele, potentially appealing to enterprise buyers and hospital systems seeking advanced treatment models.

Growth potential With a mid-sized team and a space that overlaps with established providers, there is room for partnerships to accelerate growth through white-label solutions, referral networks, and joint ventures, especially given similarities with sizable players in the addiction treatment market.

Similar companies to Leayf - Drug and Alcohol Treatment Programs

Leayf - Drug and Alcohol Treatment Programs's Email Address Formats

Leayf - Drug and Alcohol Treatment Programs uses at least 0 email formats:
Leayf - Drug and Alcohol Treatment Programs Email FormatsExamplePercentage

Frequently Asked Questions

What is Leayf - Drug and Alcohol Treatment Programs's official website and social media links?

Minus sign iconPlus sign icon
Leayf - Drug and Alcohol Treatment Programs's official website is leayf.com and has social profiles on LinkedIn.

What is Leayf - Drug and Alcohol Treatment Programs's NAICS code?

Minus sign iconPlus sign icon
Leayf - Drug and Alcohol Treatment Programs's NAICS code is 62133 - Offices of Mental Health Practitioners (except Physicians).

How many employees does Leayf - Drug and Alcohol Treatment Programs have currently?

Minus sign iconPlus sign icon
As of July 2026, Leayf - Drug and Alcohol Treatment Programs has approximately 201 employees across 3 continents, including North America, Asia and Europe. Key team members include Owner: A. G., Owner: M. L. and Owner: T. V. Explore Leayf - Drug and Alcohol Treatment Programs's employee directory with LeadIQ.

What industry does Leayf - Drug and Alcohol Treatment Programs belong to?

Minus sign iconPlus sign icon
Leayf - Drug and Alcohol Treatment Programs operates in the Mental Health Care industry.
Leayf - Drug and Alcohol Treatment Programs logo

Leayf - Drug and Alcohol Treatment Programs

Mental Health CareMissouri, United States201-500 Employees

Leayf provides treatment programs for professionals facing alcohol or drug use issues. Based in St. Louis, Missouri, the organization combines medical approaches to addiction with highly specialized therapy. Care is delivered through digital channels and in-person sessions.

The company operates within the mental health care sector, focusing on substance use disorders. It is a mid-sized organization with hundreds of employees. Its offerings combine addiction medicine practices with specialized therapy delivered through remote access and in-person sessions.

Section iconCompany Overview

Website
leayf.com
NAICS Code
62133 - Offices of Mental Health Practitioners (except Physicians)
Employees
201-500

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.